Neurological: Frequently Asked Questions

Neurology covers a broad and clinically demanding landscape — from stroke and epilepsy to movement disorders and demyelinating disease. These questions address the scope of neurological care, how diagnosis and classification work, which regulatory and credentialing frameworks govern the field, and what patients and caregivers can expect when engaging with neurological medicine. The answers draw on established public sources and reflect the operational realities of US-based neurological practice.

Where can authoritative references be found?

The primary bodies producing clinical and regulatory guidance for neurology in the United States include the American Academy of Neurology (AAN), the National Institute of Neurological Disorders and Stroke (NINDS), the Centers for Disease Control and Prevention (CDC), and the Joint Commission. The AAN publishes evidence-based clinical practice guidelines covering conditions ranging from migraine to amyotrophic lateral sclerosis, and these guidelines are freely accessible through the AAN's public portal at aan.com. NINDS, a component of the National Institutes of Health (NIH), maintains condition-specific fact sheets and funds the majority of federally supported neurological research in the US. For drug-specific information — including approved indications for neurological agents — the US Food and Drug Administration (FDA) maintains labeling databases through DailyMed. The neurological-authority index offers an organized starting point for navigating condition-specific and specialty content across the full scope of the field.

How do requirements vary by jurisdiction or context?

Neurology practice requirements differ across three primary axes: licensure, facility type, and insurance coverage rules. Medical licensure is state-specific; all 50 states and the District of Columbia require independent licensure through their respective medical boards, even for physicians holding American Board of Psychiatry and Neurology (ABPN) board certification. Scope-of-practice rules — particularly for advanced practice providers performing neurological assessments — vary significantly; full-practice authority for nurse practitioners exists in 27 states as of the most recent National Council of State Boards of Nursing (NCSBN) mapping. At the facility level, hospital credentialing committees set independent requirements for performing procedures such as lumbar puncture or interpreting electroencephalograms. Medicare and Medicaid coverage determinations, issued by the Centers for Medicare and Medicaid Services (CMS), establish reimbursement boundaries that directly affect which diagnostic tests — such as MRI of the brain and spine — are covered for specific indications.

What triggers a formal review or action?

Formal review in neurological contexts arises from at least 4 distinct triggers:

  1. Adverse event reporting — Unexpected patient harm during a neurological procedure (e.g., post-lumbar puncture complication) triggers mandatory incident reporting under Joint Commission standards and, in some cases, state department of health regulations.
  2. Board certification lapses — The ABPN requires maintenance of certification (MOC) through a continuous assessment pathway; failure to meet MOC requirements can result in certification suspension, which may trigger hospital privileging review.
  3. Drug safety signals — Post-market safety reports submitted to the FDA's MedWatch system for neurological medications (e.g., seizure threshold alterations by certain agents) can trigger label updates or Risk Evaluation and Mitigation Strategy (REMS) requirements.
  4. Mandatory reporting of specific conditions — Epilepsy-related driving restrictions and mandatory physician reporting laws exist in 43 states, requiring physicians to notify the department of motor vehicles when a patient's seizure disorder meets statutory reporting criteria.

Understanding these triggers is relevant both to regulatory context for neurological conditions and to individual patient planning around diagnosis disclosure.

How do qualified professionals approach this?

Board-certified neurologists complete a minimum of 4 years of medical school, 1 year of internship, and 3 years of accredited neurology residency (Accreditation Council for Graduate Medical Education, ACGME-approved programs). Many pursue an additional 1–2 year fellowship in subspecialties such as vascular neurology, epilepsy, or neuromuscular medicine. The diagnostic approach is systematic: clinical history and neurological examination establish the anatomical localization first — that is, identifying whether the lesion is cortical, subcortical, spinal, peripheral nerve, neuromuscular junction, or muscle — before imaging or electrophysiology is ordered. This localization-first principle, formalized in neurology training for over a century, prevents the misuse of expensive or invasive tests. Electrophysiologic studies such as EMG and nerve conduction studies and electroencephalogram are interpreted by the neurologist within a full clinical context, not in isolation.

What should someone know before engaging?

Before a neurology appointment, the referring framework matters. A primary care physician referral is typically required under most managed care and Medicare Advantage plans, though self-referral is structurally permitted in fee-for-service Medicare. Patients should arrive with a complete medication list — including supplements, since agents such as high-dose fish oil affect coagulation parameters relevant to procedural planning — and a documented seizure or symptom diary if episodic events are the presenting concern. For conditions where timing is critical, such as stroke, the window for tissue plasminogen activator (tPA) administration is 3–4.5 hours from symptom onset under AHA/ASA guidelines, making pre-engagement knowledge of warning signs directly outcome-relevant. Relevant background on signs that warrant a neurologist visit and safety boundaries in neurological care is available for deeper orientation.

What does this actually cover?

Neurology as a discipline covers disorders of the central nervous system (brain and spinal cord), the peripheral nervous system, the autonomic nervous system, and the neuromuscular junction and muscles. Formally, the ABPN defines the specialty as encompassing diagnosis and treatment of all categories of nervous system disease. Conditions addressed include but are not limited to:

Pediatric neurological conditions are addressed within the distinct subspecialty of pediatric neurology.

What are the most common issues encountered?

Across US neurology practice, the 5 most frequently encountered diagnostic categories — as reflected in NINDS epidemiological data and AAN patient population surveys — are headache disorders (migraine affects approximately 39 million Americans according to the Migraine Research Foundation), epilepsy (affecting approximately 3.4 million Americans per CDC estimates), stroke (approximately 795,000 cases annually in the US, per the CDC), peripheral neuropathy, and dementia. Diagnostic delay is a recognized systemic problem: the average time from first symptom to confirmed diagnosis for multiple sclerosis has historically ranged from 3 to 5 years, according to data published in the journal Multiple Sclerosis and Related Disorders. Access gaps represent a parallel structural issue — the Association of American Medical Colleges (AAMC) projects a shortage of neurologists that will affect rural and underserved populations disproportionately through 2034. Persistent headaches, numbness and weakness, and dizziness and balance problems are among the most common presenting complaints that drive initial referrals.

How does classification work in practice?

Neurological classification operates at two levels: anatomical localization and etiological categorization. Anatomical localization — determining where in the nervous system the lesion or dysfunction resides — is the foundational step and precedes etiological diagnosis. The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), maintained by the CDC and CMS, provides the formal coding framework used across US clinical and billing contexts. Chapter 6 of ICD-10-CM (codes G00–G99) covers diseases of the nervous system.

Epilepsy classification follows the International League Against Epilepsy (ILAE) framework, which organizes seizures by onset type (focal, generalized, or unknown), seizure type, and epilepsy syndrome. Stroke is classified by mechanism — ischemic (approximately 87% of all strokes, per American Stroke Association data) versus hemorrhagic — with ischemic strokes further subclassified using the TOAST (Trial of Org 10172 in Acute Stroke Treatment) criteria into cardioembolic, large-vessel atherosclerotic, small-vessel occlusive, other determined etiology, and undetermined etiology. This contrast between localization-first and etiology-first reasoning is one of the defining analytical features separating neurology from other internal medicine subspecialties. Treatment pathways — including medications for neurological conditions, deep brain stimulation, and rehabilitation after neurological injury — are selected only after classification is established with sufficient confidence.

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)